1.Rapid Identification of Different Parts of Nardostachys jatamansi Based on HS-SPME-GC-MS and Ultra-fast Gas Phase Electronic Nose
Tao WANG ; Xiaoqin ZHAO ; Yang WEN ; Momeimei QU ; Min LI ; Jing WEI ; Xiaoming BAO ; Ying LI ; Yuan LIU ; Xiao LUO ; Wenbing LI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(2):182-191
ObjectiveTo establish a model that can quickly identify the aroma components in different parts of Nardostachys jatamansi, so as to provide a quality control basis for the market circulation and clinical use of N. jatamansi. MethodsHeadspace solid-phase microextraction-gas chromatography-mass spectrometry(HS-SPME-GC-MS) combined with Smart aroma database and National Institute of Standards and Technology(NIST) database were used to characterize the aroma components in different parts of N. jatamansi, and the aroma components were quantified according to relative response factor(RRF) and three internal standards, and the markers of aroma differences in different parts of N. jatamansi were identified by orthogonal partial least squares-discriminant analysis(OPLS-DA) and cluster thermal analysis based on variable importance in the projection(VIP) value >1 and P<0.01. The odor data of different parts of N. jatamansi were collected by Heracles Ⅱ Neo ultra-fast gas phase electronic nose, and the correlation between compound types of aroma components collected by the ultra-fast gas phase electronic nose and the detection results of HS-SPME-GC-MS was investigated by drawing odor fingerprints and odor response radargrams. Chromatographic peak information with distinguishing ability≥0.700 and peak area≥200 was selected as sensor data, and the rapid identification model of different parts of N. jatamansi was established by principal component analysis(PCA), discriminant factor alysis(DFA), soft independent modeling of class analogies(SIMCA) and statistical quality control analysis(SQCA). ResultsThe HS-SPME-GC-MS results showed that there were 28 common components in the underground and aboveground parts of N. jatamansi, of which 22 could be quantified and 12 significantly different components were screened out. Among these 12 components, the contents of five components(ethyl isovalerate, 2-pentylfuran, benzyl alcohol, nonanal and glacial acetic acid,) in the aboveground part of N. jatamansi were significantly higher than those in the underground part(P<0.01), the contents of β-ionone, patchouli alcohol, α-caryophyllene, linalyl butyrate, valencene, 1,8-cineole and p-cymene in the underground part of N. jatamansi were significantly higher than those in the aboveground part(P<0.01). Heracles Ⅱ Neo electronic nose results showed that the PCA discrimination index of the underground and aboveground parts of N. jatamansi was 82, and the contribution rates of the principal component factors were 99.94% and 99.89% when 2 and 3 principal components were extracted, respectively. The contribution rate of the discriminant factor 1 of the DFA model constructed on the basis of PCA was 100%, the validation score of the SIMCA model for discrimination of the two parts was 99, and SQCA could clearly distinguish different parts of N. jatamansi. ConclusionHS-SPME-GC-MS can clarify the differential markers of underground and aboveground parts of N. jatamansi. The four analytical models provided by Heracles Ⅱ Neo electronic nose(PCA, DFA, SIMCA and SQCA) can realize the rapid identification of different parts of N. jatamansi. Combining the two results, it is speculated that terpenes and carboxylic acids may be the main factors contributing to the difference in aroma between the underground and aboveground parts of N. jatamansi.
2.Design, synthesis and anti-Alzheimer's disease activity evaluation of cinnamyl triazole compounds
Wen-ju LEI ; Zhong-di CAI ; Lin-jie TAN ; Mi-min LIU ; Li ZENG ; Ting SUN ; Hong YI ; Rui LIU ; Zhuo-rong LI
Acta Pharmaceutica Sinica 2025;60(1):150-163
19 cinnamamide/ester-triazole compounds were designed, synthesized and evaluated for their anti-Alzheimer's disease (AD) activity. Among them, compound
3.Effects of Compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata on ILC2s-Related Factors in Lung of Allergic Rhinitis Model Mice
Yi ZHANG ; Xiaohua TAO ; Min LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(11):51-59
ObjectiveTo explore the effects of compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata on the expression of type 2 innate lymphoid cells(ILC2s)-related factors in the lung of allergic rhinitis(AR)mice. MethodsAccording to the random number table method,fifty-four C57BL/6J mice were randomly divided into the following groups: Blank group,model group,Mahuang Fuzi Xixintang group,Asari Radix et Rhizoma and Aconiti Lateralis Radix Praeparata group,Ephedrae Herba and Asari Radix et Rhizoma group,Ephedrae Herba and Aconiti Lateralis Radix Praeparata group,Ephedrae Herba group,Aconiti Lateralis Radix Praeparata group, and Asari Radix et Rhizoma group (6 mice in each group). Except the blank group,the other groups were subjected to intraperitoneal injection of ovalbumin(OVA)and intranasal challenge to induce AR. After the AR model was established,the mice in the blank group and the model group were given 0.2 mL·d-1 normal saline by gavage,while those in the Mahuang Fuzi Xixintang group(2.31 g·kg-1),Asari Radix et Rhizoma and Aconiti Lateralis Radix Praeparata group(1.54 g·kg-1), Ephedrae Herba and Asari Radix et Rhizoma group(1.16 g·kg-1), Ephedrae Herba and Aconiti Lateralis Radix Praeparata group(1.93 g·kg-1),Ephedrae Herba group(0.77 g·kg-1),Aconiti Lateralis Radix Praeparata group(1.16 g·kg-1),and Asari Radix et Rhizoma group(0.39 g·kg-1)were given corresponding medicine by gavage,with the treatment lasting for 14 consecutive days. The survival state of mice in each group was observed, and the levels of serum immunoglobulins E(IgE)after intranasal challenge were measured by enzyme-linked immunosorbent assay(ELISA). The pathological changes of nasal and lung tissues were observed by hematoxylin-eosin(HE)staining. The expression of ILC2s in lung tissue of mice was detected by immunofluorescence(IF). The mRNA expression of GATA binding protein 3(GATA3),retinoic acid receptor-related orphan receptor-α(RORα), and inhibitor of DNA binding 2(ID2)in the lung tissue of mice was detected by quantitative real-time polymerase chain reaction(real-time PCR). The levels of IgE,interleukin(IL)-4,IL-5, and IL-13 in serum were detected by ELISA. ResultsCompared with the blank group,the model group had poor survival state of mice and significantly increased serum IgE level after intranasal challenge(p<0.01). Additionally,the mice in the model group showed a large amount of neutrophil infiltration in the mucosa of the posterior turbinate, obvious nasal mucosal bleeding and purulent secretion,shed epithelium, thickened bronchial wall,obvious intravascular hyperemia and edema,diffusion and infiltration of a large number of inflammatory cells,seriously damaged alveolar structure,and local lung consolidation. The model group also exhibited significantly increased expression of ILC2s in the lung tissue(P<0.01),increased mRNA expression of GATA3 and RORα,decreased mRNA expression of ID2(P<0.05,P<0.01),and increased levels of serum IgE, IL-4,IL-5,and IL-13(P<0.05,P<0.01). Compared with the model group,the Mahuang Fuzi Xixintang group and the other medicine treatment groups showed improved survival state of mice, significantly reduced inflammatory cell infiltration in the nasal and lung tissues,a small amount of nasal mucosal bleeding,trachea wall thinning,and no hyperemia,edema, and nasal secretions. Furthermore, the expression of ILC2s in lung tissue was significantly decreased(P<0.01). The mRNA expression level of GATA3 was decreased(P<0.05),especially in the Aconiti Lateralis Radix Praeparata group(P<0.01). The expression mRNA levels of RORα were decreased only in the Ephedrae Herba and Aconiti Lateralis Radix Praeparata group and the Ephedrae Herba group(P<0.05). The levels of serum IgE were decreased(P<0.05), and IL-5 levels were significantly decreased(P<0.01). IL-4 levels were significantly decreased in the groups except the Aconiti Lateralis Radix Praeparata group(P<0.01),and the level of IL-13 in the Mahuang Fuzi Xixintang group was decreased(P<0.05). The levels of IL-13 in were significantly decreased in the Ephedrae Herba and Aconiti Lateralis Radix Praeparata group, Ephedrae Herba group, Aconiti Lateralis Radix Praeparata group, and Asari Radix et Rhizoma group(P<0.01). ConclusionDifferent compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata can reduce the inflammation of OVA-induced AR mice and has more advantages in reducing the secretion of IgE and IL-5. The compatibility of Ephedrae Herba and Aconiti Lateralis Radix Praeparata has the most advantage in reducing the mRNA expression of GATA3 and RORα to inhibit the expression of ILC2s and thus exert the anti-allergic effect,while the other compatibility has the extensive advantage in inhibiting the mRNA expression of GATA3.
4.Effects of Compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata on ILC2s-Related Factors in Lung of Allergic Rhinitis Model Mice
Yi ZHANG ; Xiaohua TAO ; Min LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(11):51-59
ObjectiveTo explore the effects of compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata on the expression of type 2 innate lymphoid cells(ILC2s)-related factors in the lung of allergic rhinitis(AR)mice. MethodsAccording to the random number table method,fifty-four C57BL/6J mice were randomly divided into the following groups: Blank group,model group,Mahuang Fuzi Xixintang group,Asari Radix et Rhizoma and Aconiti Lateralis Radix Praeparata group,Ephedrae Herba and Asari Radix et Rhizoma group,Ephedrae Herba and Aconiti Lateralis Radix Praeparata group,Ephedrae Herba group,Aconiti Lateralis Radix Praeparata group, and Asari Radix et Rhizoma group (6 mice in each group). Except the blank group,the other groups were subjected to intraperitoneal injection of ovalbumin(OVA)and intranasal challenge to induce AR. After the AR model was established,the mice in the blank group and the model group were given 0.2 mL·d-1 normal saline by gavage,while those in the Mahuang Fuzi Xixintang group(2.31 g·kg-1),Asari Radix et Rhizoma and Aconiti Lateralis Radix Praeparata group(1.54 g·kg-1), Ephedrae Herba and Asari Radix et Rhizoma group(1.16 g·kg-1), Ephedrae Herba and Aconiti Lateralis Radix Praeparata group(1.93 g·kg-1),Ephedrae Herba group(0.77 g·kg-1),Aconiti Lateralis Radix Praeparata group(1.16 g·kg-1),and Asari Radix et Rhizoma group(0.39 g·kg-1)were given corresponding medicine by gavage,with the treatment lasting for 14 consecutive days. The survival state of mice in each group was observed, and the levels of serum immunoglobulins E(IgE)after intranasal challenge were measured by enzyme-linked immunosorbent assay(ELISA). The pathological changes of nasal and lung tissues were observed by hematoxylin-eosin(HE)staining. The expression of ILC2s in lung tissue of mice was detected by immunofluorescence(IF). The mRNA expression of GATA binding protein 3(GATA3),retinoic acid receptor-related orphan receptor-α(RORα), and inhibitor of DNA binding 2(ID2)in the lung tissue of mice was detected by quantitative real-time polymerase chain reaction(real-time PCR). The levels of IgE,interleukin(IL)-4,IL-5, and IL-13 in serum were detected by ELISA. ResultsCompared with the blank group,the model group had poor survival state of mice and significantly increased serum IgE level after intranasal challenge(p<0.01). Additionally,the mice in the model group showed a large amount of neutrophil infiltration in the mucosa of the posterior turbinate, obvious nasal mucosal bleeding and purulent secretion,shed epithelium, thickened bronchial wall,obvious intravascular hyperemia and edema,diffusion and infiltration of a large number of inflammatory cells,seriously damaged alveolar structure,and local lung consolidation. The model group also exhibited significantly increased expression of ILC2s in the lung tissue(P<0.01),increased mRNA expression of GATA3 and RORα,decreased mRNA expression of ID2(P<0.05,P<0.01),and increased levels of serum IgE, IL-4,IL-5,and IL-13(P<0.05,P<0.01). Compared with the model group,the Mahuang Fuzi Xixintang group and the other medicine treatment groups showed improved survival state of mice, significantly reduced inflammatory cell infiltration in the nasal and lung tissues,a small amount of nasal mucosal bleeding,trachea wall thinning,and no hyperemia,edema, and nasal secretions. Furthermore, the expression of ILC2s in lung tissue was significantly decreased(P<0.01). The mRNA expression level of GATA3 was decreased(P<0.05),especially in the Aconiti Lateralis Radix Praeparata group(P<0.01). The expression mRNA levels of RORα were decreased only in the Ephedrae Herba and Aconiti Lateralis Radix Praeparata group and the Ephedrae Herba group(P<0.05). The levels of serum IgE were decreased(P<0.05), and IL-5 levels were significantly decreased(P<0.01). IL-4 levels were significantly decreased in the groups except the Aconiti Lateralis Radix Praeparata group(P<0.01),and the level of IL-13 in the Mahuang Fuzi Xixintang group was decreased(P<0.05). The levels of IL-13 in were significantly decreased in the Ephedrae Herba and Aconiti Lateralis Radix Praeparata group, Ephedrae Herba group, Aconiti Lateralis Radix Praeparata group, and Asari Radix et Rhizoma group(P<0.01). ConclusionDifferent compatibility of Ephedrae Herba,Asari Radix et Rhizoma, and Aconiti Lateralis Radix Praeparata can reduce the inflammation of OVA-induced AR mice and has more advantages in reducing the secretion of IgE and IL-5. The compatibility of Ephedrae Herba and Aconiti Lateralis Radix Praeparata has the most advantage in reducing the mRNA expression of GATA3 and RORα to inhibit the expression of ILC2s and thus exert the anti-allergic effect,while the other compatibility has the extensive advantage in inhibiting the mRNA expression of GATA3.
5.Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer
Fang LEE ; Shih-Ping CHENG ; Ming-Jen CHEN ; Wen-Chien HUANG ; Yi-Min LIU ; Shao-Chiang CHANG ; Yuan-Ching CHANG
Journal of Breast Cancer 2025;28(2):86-98
Purpose:
Zinc finger protein 639 (ZNF639) is often found within the overlapping amplicon of PIK3CA, and previous studies suggest its involvement in the pathogenesis of esophageal and oral squamous cell carcinomas. However, its expression and significance in breast cancer remain uncharacterized.
Methods:
Immunohistochemical analysis of ZNF639 was performed using tissue microarrays.Functional studies, including colony formation, Transwell cell migration, and in vivo metastasis, were conducted on breast tumor cells with ZNF639 knockdown via small interfering RNA transfection.
Results:
Reduced ZNF639 immunoreactivity was observed in 82% of the breast cancer samples, independent of hormone receptor and human epidermal growth factor receptor 2 status. In multivariate Cox regression analyses, ZNF639 expression was associated with favorable survival outcomes, including recurrence-free survival (hazard ratio, 0.35; 95% confidence interval [CI], 0.14–0.89) and overall survival (hazard ratio, 0.41; 95% CI, 0.16– 1.05). ZNF639 knockdown increased clonogenicity, cell motility, and lung metastasis in NOD/ SCID mice. Following the ZNF639 knockdown, the expression of Snail1, vimentin, and C-C chemokine ligand 20 (CCL20) was upregulated, and the changes in cell phenotype mediated by ZNF639 were reversed by the subsequent knockdown of CCL20.
Conclusion
Low ZNF639 expression is a novel prognostic factor for recurrence-free survival in patients with breast cancer.
6.Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer
Fang LEE ; Shih-Ping CHENG ; Ming-Jen CHEN ; Wen-Chien HUANG ; Yi-Min LIU ; Shao-Chiang CHANG ; Yuan-Ching CHANG
Journal of Breast Cancer 2025;28(2):86-98
Purpose:
Zinc finger protein 639 (ZNF639) is often found within the overlapping amplicon of PIK3CA, and previous studies suggest its involvement in the pathogenesis of esophageal and oral squamous cell carcinomas. However, its expression and significance in breast cancer remain uncharacterized.
Methods:
Immunohistochemical analysis of ZNF639 was performed using tissue microarrays.Functional studies, including colony formation, Transwell cell migration, and in vivo metastasis, were conducted on breast tumor cells with ZNF639 knockdown via small interfering RNA transfection.
Results:
Reduced ZNF639 immunoreactivity was observed in 82% of the breast cancer samples, independent of hormone receptor and human epidermal growth factor receptor 2 status. In multivariate Cox regression analyses, ZNF639 expression was associated with favorable survival outcomes, including recurrence-free survival (hazard ratio, 0.35; 95% confidence interval [CI], 0.14–0.89) and overall survival (hazard ratio, 0.41; 95% CI, 0.16– 1.05). ZNF639 knockdown increased clonogenicity, cell motility, and lung metastasis in NOD/ SCID mice. Following the ZNF639 knockdown, the expression of Snail1, vimentin, and C-C chemokine ligand 20 (CCL20) was upregulated, and the changes in cell phenotype mediated by ZNF639 were reversed by the subsequent knockdown of CCL20.
Conclusion
Low ZNF639 expression is a novel prognostic factor for recurrence-free survival in patients with breast cancer.
7.Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer
Fang LEE ; Shih-Ping CHENG ; Ming-Jen CHEN ; Wen-Chien HUANG ; Yi-Min LIU ; Shao-Chiang CHANG ; Yuan-Ching CHANG
Journal of Breast Cancer 2025;28(2):86-98
Purpose:
Zinc finger protein 639 (ZNF639) is often found within the overlapping amplicon of PIK3CA, and previous studies suggest its involvement in the pathogenesis of esophageal and oral squamous cell carcinomas. However, its expression and significance in breast cancer remain uncharacterized.
Methods:
Immunohistochemical analysis of ZNF639 was performed using tissue microarrays.Functional studies, including colony formation, Transwell cell migration, and in vivo metastasis, were conducted on breast tumor cells with ZNF639 knockdown via small interfering RNA transfection.
Results:
Reduced ZNF639 immunoreactivity was observed in 82% of the breast cancer samples, independent of hormone receptor and human epidermal growth factor receptor 2 status. In multivariate Cox regression analyses, ZNF639 expression was associated with favorable survival outcomes, including recurrence-free survival (hazard ratio, 0.35; 95% confidence interval [CI], 0.14–0.89) and overall survival (hazard ratio, 0.41; 95% CI, 0.16– 1.05). ZNF639 knockdown increased clonogenicity, cell motility, and lung metastasis in NOD/ SCID mice. Following the ZNF639 knockdown, the expression of Snail1, vimentin, and C-C chemokine ligand 20 (CCL20) was upregulated, and the changes in cell phenotype mediated by ZNF639 were reversed by the subsequent knockdown of CCL20.
Conclusion
Low ZNF639 expression is a novel prognostic factor for recurrence-free survival in patients with breast cancer.
8.Role of mitochondrial division/fusion in different liver diseases
Yuanqian MIN ; Shan LI ; Xianghua LIU ; Yi YANG ; Baoping LU
Journal of Clinical Hepatology 2025;41(9):1937-1942
Mitochondria are abundant in hepatocytes and play an important role in the normal operation of the liver. Mitochondrial division/fusion is two biological processes that maintain the dynamic balance of mitochondria, and it is closely associated with the change of cell function and the development and progression of diseases. Balance of mitochondrial division/fusion is of key significance in the treatment of many diseases. Recent studies have shown that abnormal mitochondrial division/fusion plays a significant role in fatty liver disease, hepatitis, liver fibrosis, and liver cancer, which are the four stages of the progression of liver diseases, and the therapeutic targets based on the regulation of such abnormalities are constantly being identified. By reviewing the role of mitochondrial division/fusion in different stages of liver disease, this article further demonstrates the role of mitochondrial division/fusion mechanism in chronic liver diseases and also provides a scientific basis for more ideas on the treatment, remission or even reversal of liver disease progression based on mitochondrial division/fusion.
9.Advances in application of small-molecule compounds in neuronal reprogramming.
Zi-Wei DAI ; Hong LIU ; Yi-Min YUAN ; Jing-Yi ZHANG ; Shang-Yao QIN ; Zhi-Da SU
Acta Physiologica Sinica 2025;77(1):181-193
Neuronal reprogramming is an innovative technique for converting non-neuronal somatic cells into neurons that can be used to replace lost or damaged neurons, providing a potential effective therapeutic strategy for central nervous system (CNS) injuries or diseases. Transcription factors have been used to induce neuronal reprogramming, while their reprogramming efficiency is relatively low, and the introduction of exogenous genes may result in host gene instability or induce gene mutation. Therefore, their future clinical application may be hindered by these safety concerns. Compared with transcription factors, small-molecule compounds have unique advantages in the field of neuronal reprogramming, which can overcome many limitations of traditional transcription factor-induced neuronal reprogramming. Here, we review the recent progress in the research of small-molecule compound-mediated neuronal reprogramming and its application in CNS regeneration and repair.
Humans
;
Cellular Reprogramming/drug effects*
;
Neurons/cytology*
;
Animals
;
Transcription Factors
;
Small Molecule Libraries/pharmacology*
;
Nerve Regeneration
10.Buzhong Yiqi Decoction alleviates immune injury of autoimmune thyroiditis in NOD.H-2~(h4)mice via c GAS-STING signaling pathway.
Yi-Ran CHEN ; Lan-Ting WANG ; Qing-Yang LIU ; Zhao-Han ZHAI ; Shou-Xin JU ; Xue-Ying CHEN ; Zi-Yu LIU ; Xiao YANG ; Tian-Shu GAO ; Zhi-Min WANG
China Journal of Chinese Materia Medica 2025;50(7):1872-1880
This study aims to explore the effects of Buzhong Yiqi Decoction(BYD) on the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING) signaling pathway in the mouse model of autoimmune thyroiditis(AIT) and the mechanism of BYD in alleviating the immune injury. Forty-eight NOD.H-2~(h4) mice were assigned into normal, model, low-, medium-, and high-dose BYD, and selenium yeast tablets groups(n=8). Mice of 8 weeks old were treated with 0.05% sodium iodide solution for 8 weeks for the modeling of AIT and then administrated with corresponding drugs by gavage for 8 weeks before sampling. High performance liquid chromatography was employed to measure the astragaloside Ⅳ content in BYD. Hematoxylin-eosin staining was employed to observe the pathological changes in the mouse thyroid tissue. Enzyme-linked immunosorbent assay was employed to measure the serum levels of thyroid peroxidase antibody(TPO-Ab), thyroglobulin antibody(TgAb), and interferon-γ(IFN-γ). Flow cytometry was employed to detect the distribution of T cell subsets in the spleen. The immunohistochemical method was used to detect the expression of cGAS, STING, TANK-binding kinase 1(TBK1), and interferon regulatory factor 3(IRF3). Real-time PCR and Western blot were employed to determine the mRNA and protein levels, respectively, of markers related to the cGAS-STING signaling pathway in the thyroid tissue. The results showed that the content of astragaloside Ⅳ in BYD was(7.06±0.08) mg·mL~(-1). Compared with the normal group, the model group showed disrupted structures of thyroid follicular epithelial cells, massive infiltration of lymphocytes, and elevated levels of TgAb and TPO-Ab. Compared with the model group, the four treatment groups showed intact epithelial cells, reduced lymphocyte infiltration, and lowered levels of TgAb and TPO-Ab. Compared with the normal group, the model group showed increases in the proportions of Th1 and Th17 cells, a decrease in the proportion of Th2 cells, and an increase in the IFN-γ level. Compared with the model group, the four treatment groups presented decreased proportions of Th1 and Th17 cells and lowered levels of IFN-γ, and the medium-dose BYD group showed an increase in the proportion of Th2 cells. Compared with the normal group, the modeling up-regulated the mRNA levels of cGAS, STING, TBK1, and IRF3 and the protein levels of cGAS, p-STING, p-TBK1, and p-IRF3. Compared with the model group, the four treatment groups showed reduced levels of cGAS, STING, TBK1, and IRF3-positive products, down-regulated mRNA levels of cGAS, STING, and TBK1, and down-regulated protein levels of cGAS and p-STING. The high-dose BYD group showed down-regulations in the mRNA level of IRF3 and the protein levels of p-TBK1 and p-IRF3. The above results indicate that BYD can repair the imbalance of T cell subsets, alleviate immune injury, and reduce thyroid lymphocyte infiltration in AIT mice by inhibiting the cGAS-STING signaling pathway.
Animals
;
Drugs, Chinese Herbal/administration & dosage*
;
Signal Transduction/drug effects*
;
Thyroiditis, Autoimmune/metabolism*
;
Mice
;
Membrane Proteins/metabolism*
;
Mice, Inbred NOD
;
Humans
;
Female
;
Nucleotidyltransferases/metabolism*
;
Male
;
Disease Models, Animal

Result Analysis
Print
Save
E-mail